1
|
Mullaivendhan J, Ahamed A, Arif IA, Raman G, Akbar I. Mushroom tyrosinase enzyme catalysis: synthesis of larvicidal active geranylacetone derivatives against Culex quinquesfasciatus and molecular docking studies. Front Chem 2024; 11:1303479. [PMID: 38268759 PMCID: PMC10806150 DOI: 10.3389/fchem.2023.1303479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 12/11/2023] [Indexed: 01/26/2024] Open
Abstract
The grindstone process, which uses tyrosinase as a catalyst, was used to create analogues of geranylacetone. Tyrosinase was used to prepare the Mannich base under favourable reaction conditions, resulting in a high yield. All synthesized compounds were characterized using FTIR, Nuclear magnetic resonance, and mass spectral analyses. The active geranylacetone derivatives (1a-l) were investigated for larvicidal activity against Culex quinquefasciatus; compound 1b (LD50:20.7 μg/mL) was noticeably more effective than geranylacetone (LD50: >100 μg/mL) and permethrin (LD50: 24.4 μg/mL) lead compounds because of their ability to kill larvae and use them as pesticides. All compounds (1a-1l) were found to be low toxic, whereas compounds 1b, 1d, and 1k were screened for antifeedant screening of non -aquatic target for the toxicity measurement against marine fish Oreochromis mossambicus at 100 μg/mL caused 0% mortality in within 24 h. Molecular docking studies of synthesised compound 1b and permethrin docked with 3OGN, compound 1b demonstrated a greater binding affinity (-9.6 kcal/mol) compared to permethrin (-10.5 kcal/mol). According to these results, the newly synthesised geranylacetone derivatives can serve as lead molecules of larvicides agents.
Collapse
Affiliation(s)
- Janani Mullaivendhan
- Research Department of Chemistry, Nehru Memorial College (Affiliated Bharathidasan University), Puthanampatti, Tamil Nadu, India
| | - Anis Ahamed
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
| | - Ibrahim A. Arif
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia
| | - Gurusamy Raman
- Department of Life Science, Yeungnam University, Gyeongsan, Republic of Korea
| | - Idhayadhulla Akbar
- Research Department of Chemistry, Nehru Memorial College (Affiliated Bharathidasan University), Puthanampatti, Tamil Nadu, India
| |
Collapse
|
2
|
Mullaivendhan J, Akbar I, Gatasheh MK, Hatamleh AA, Ahamed A, Abuthakir MHS, Gurusamy R. Cu (II)-catalyzed: synthesis of imidazole derivatives and evaluating their larvicidal, antimicrobial activities with DFT and molecular docking studies. BMC Chem 2023; 17:155. [PMID: 37980500 PMCID: PMC10657005 DOI: 10.1186/s13065-023-01067-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2023] [Accepted: 10/26/2023] [Indexed: 11/20/2023] Open
Abstract
This paper deals with the evaluation of novel imidazole molecules for their antimicrobial and larvicidal activities. A series of imidazole derivatives 1(a-f) and 2(a-e) were prepared by the Mannich base technique using a Cu(II) catalyst. The Cu(phen)Cl2 catalyst was found to be more effective than other methods. FTIR, elemental analyses, mass spectrometry, 1H NMR, and 13C NMR spectroscopy were performed to elucidate the structures of the synthesised compounds. Antimicrobial and larvicidal activities were investigated for all compounds. The antibacterial activity of compounds (2d) and (2a) were highly active in S.aureus (MIC: 0.25 μg/mL) and K.pneumoniae (MIC: 0.25 μg/mL) compared to ciprofloxacin. Compound (1c) was significantly more effective than clotrimazole in C.albicans (MIC: 0.25 μg/mL). Molecular docking studies of compound 2d showed a higher binding affinity for the 1BDD protein (- 3.4 kcal/mol) than ciprofloxacin (- 4.4 kcal/mol). Compound 1c had a higher binding affinity (- 6.0 kcal/mol) than clotrimazole (- 3.1 kcal/mol) with greater frontier molecular orbital energy and reactivity properties of compound 1c (∆E gap = 0.13 eV). The activity of compound 1a (LD50: 34.9 μg/mL) was more effective in the Culex quinquefasciatus than permethrin (LD50: 35.4 μg/mL) and its molecular docking binding affinity for 3OGN protein (- 6.1 kcal/mol). These newly synthesised compounds can act as lead molecules for the development of larvicides and antibiotic agents.
Collapse
Affiliation(s)
- Janani Mullaivendhan
- Research Department of Chemistry, Nehru Memorial College (Affiliated Bharathidasan University), Puthanampatti, 621007, Tamil Nadu, India
| | - Idhayadhulla Akbar
- Research Department of Chemistry, Nehru Memorial College (Affiliated Bharathidasan University), Puthanampatti, 621007, Tamil Nadu, India.
| | - Mansour K Gatasheh
- Department of Biochemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia
| | - Ashraf Atef Hatamleh
- Department of Botany & Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | - Anis Ahamed
- Department of Botany & Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | | | - Raman Gurusamy
- Department of Lifescience, Yeungnan University, Gyeondsan, Gyeondsan-Buk, 38541, South Korea
| |
Collapse
|
3
|
Poyraz S, Döndaş HA, Döndaş NY, Sansano JM. Recent insights about pyrrolidine core skeletons in pharmacology. Front Pharmacol 2023; 14:1239658. [PMID: 37745071 PMCID: PMC10512268 DOI: 10.3389/fphar.2023.1239658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Accepted: 07/05/2023] [Indexed: 09/26/2023] Open
Abstract
To overcome numerous health disorders, heterocyclic structures of synthetic or natural origin are utilized, and notably, the emergence of various side effects of existing drugs used for treatment or the resistance of disease-causing microorganisms renders drugs ineffective. Therefore, the discovery of potential therapeutic agents that utilize different modes of action is of utmost significance to circumvent these constraints. Pyrrolidines, pyrrolidine-alkaloids, and pyrrolidine-based hybrid molecules are present in many natural products and pharmacologically important agents. Their key roles in pharmacotherapy make them a versatile scaffold for designing and developing novel biologically active compounds and drug candidates. This review aims to provide an overview of recent advancements (especially during 2015-2023) in the exploration of pyrrolidine derivatives, emphasizing their significance as fundamental components of the skeletal structure. In contrast to previous reviews that have predominantly focused on a singular biological activity associated with these molecules, this review consolidates findings from various investigations encompassing a wide range of important activities (antimicrobial, antiviral, anticancer, anti-inflammatory, anticonvulsant, cholinesterase inhibition, and carbonic anhydrase inhibition) exhibited by pyrrolidine derivatives. This study is also anticipated to serve as a valuable resource for drug research and development endeavors, offering significant insights and guidance.
Collapse
Affiliation(s)
- Samet Poyraz
- Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Çukurova University, Adana, Türkiye
| | - H. Ali Döndaş
- Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Çukurova University, Adana, Türkiye
- Department of Biotechnology, Institute of Natural and Applied Sciences, Çukurova University, Adana, Türkiye
| | | | - José M. Sansano
- Department of Organic Chemistry, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Instituto de Síntesis Orgánica (ISO), University of Alicante, Alicante, Spain
| |
Collapse
|
4
|
Ang S, Cao N, Zheng W, Zhang Z, Li J, Yan Z, Su K, Wong WL, Zhang K, Hong WD, Wu P. Novel Sophoridine Derivatives as Potential Larvicidal Agents against Aedes albopictus: Synthesis, Biological Evaluation, Acetylcholinesterase Inhibition, and Morphological Study. INSECTS 2023; 14:399. [PMID: 37103214 PMCID: PMC10140878 DOI: 10.3390/insects14040399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 04/18/2023] [Accepted: 04/19/2023] [Indexed: 06/19/2023]
Abstract
Two series of novel sophoridine derivatives were designed, synthesized, and evaluated for their anti-mosquito activity. SOP-2g, SOP-2q, and SOP-2r exhibited potential larvicidal activity against Aedes albopictus larva with LC50 values of 330.98, 430.53, and 411.09 ppm, respectively. Analysis of structure-activity relationships indicated that the oxime ester group was beneficial for improving the larvicidal biological activity, whereas the long-chain aliphatic group and fused-ring group were introduced. Furthermore, the larvicidal mechanism was also investigated based on the inhibition assay of acetylcholinesterase (AChE) and the morphological observation of dead larva treated with derivatives. Results indicated that the AChE inhibitory activity of the preferred three derivatives were 63.16%, 46.67%, and 35.11%, respectively, at 250 ppm concentration. Additionally, morphological evidence demonstrated that SOP-2q and SOP-2r induced changes in the larva's intestinal cavity, caudal gill, and tail, thereby displaying larvicidal action against Ae. albopictus together with AChE inhibition. Therefore, this study implied that sophoridine and its novel derivatives could be used to control the population of mosquito larva, which may also be effective alkaloids to reduce the mosquito population density.
Collapse
Affiliation(s)
- Song Ang
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Nana Cao
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Wende Zheng
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Zhen Zhang
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Jinxuan Li
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Zhenping Yan
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Kaize Su
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Wing-Leung Wong
- The State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China
| | - Kun Zhang
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Weiqian David Hong
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Panpan Wu
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China (W.Z.); (K.Z.)
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| |
Collapse
|